Taskinen, M., Björnson, E., Kahri, J., Söderlund, S., Matikainen, N., Porthan, K., Ainola, M., Hakkarainen, A., Lundbom, N., Fermanelli, V., Fuchs, J., Thorsell, A., Kronenberg, F., Andersson, L., Adiels, M., Packard, C. J., & Borén, J. (2021). effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes. Arteriosclerosis, thrombosis, and vascular biology, 41(2), . http://access.bl.uk/ark:/81055/vdc_100147205642.0x000018